Skip to Main Content (Press Enter)

Logo UNISR
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills
  • Equipment

UNIFIND
Logo UNISR

|

UNIFIND

unisr.it
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills
  • Equipment
  1. Outputs

Anti-Programmed Cell Death 1/Ligand 1 (PD-1/PD-L1) Antibodies for the Treatment of Urothelial Carcinoma: State of the Art and Future Development

Academic Article
Publication Date:
2018
Short description:
Anti-Programmed Cell Death 1/Ligand 1 (PD-1/PD-L1) Antibodies for the Treatment of Urothelial Carcinoma: State of the Art and Future Development / Powles, T., Necchi, A., Rosen, G., Hariharan, S., Apolo, A.b.. - In: CLINICAL GENITOURINARY CANCER. - ISSN 1558-7673. - 16:2(2018), pp. 117-129. [10.1016/j.clgc.2017.11.002]
Iris type:
1.1 Articolo in rivista
List of contributors:
Powles, T; Necchi, A; Rosen, G; Hariharan, S; Apolo, Ab
Authors of the University:
NECCHI ANDREA
Handle:
https://iris.unisr.it/handle/20.500.11768/105957
Published in:
CLINICAL GENITOURINARY CANCER
Journal
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.11.1.0